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Geneticization?
Since the start of the Human Genome Project there has been much speculation on the impact of this mega-research project on medicine and health care. Various authors have argued that growing attention on the genetic factors in the emergence of diseases will lead to their geneticization: it would define diseases increasingly in terms of DNA (Ten Have, 2001 ). Geneticization, according to the sociologist Lippman, means 'the ongoing process by which priority is given to differences between individuals based on their DNA codes, with most disorders, behaviours and physiological variation … structured, at least in part, hereditary ' (Lippman 1993, p. 178) . Several authors fear that the rise of this genetic perspective will result in a devaluation of social or cultural approaches to health and disease. After all, if genes are decisive in determining the boundary between pathology and health, is there still any relevancy to social or cultural explanations for health or disease? Will there be room left for individual meanings of health and disease? The geneticization thesis implies the expectation that on account of the increased usage of genetic tests, people are tied to their biological fate and that their freedom to fashion their own lives is seriously threatened.
The geneticization thesis has met with criticism, however. This criticism primarily has a methodic character. According to Hedgecoe, the concept of geneticization is much too speculative and monolithic for an adequate analysis of the effects of the introduction of genetic technology in health care (Hedgecoe 2001) . This concept goes hand in hand with the view that geneticization is a necessary and unavoidable effect of genetic technology and does little justice to the human effort involved in the introduction of new medical techniques. The geneticization thesis would also shed insufficient light on the influence of critical discussions about DNA technology as to how these techniques ultimately become embedded in society. When starting from the geneticization thesis, little is to be expected from public debate and reflection because most power is attributed to the technology itself. Based on this specific critique, Hedgecoe argues for investigating the effects of genetic technology, rather than simply assuming them. This will allow one to assess whether the claim implied by the geneticization thesis -the increasing definition of disease and health in terms of genes -will hold. He considers it the task of the social sciences to enrich the debate on genetic technology with empirically informed analyses.
In this chapter, which takes Hedgecoe's suggestion to heart, I trace the introduction of genetic technology in the area of cardiovascular diseases with the aim of making visible the human effort involved and to generate new normative questions and reflection, instead of creating fear.
During the past four decades, cardiovascular diseases have mainly been associated with the risks of a specifically Western lifestyle. Although recently these diseases 1 have also been linked specifically to the dietary and smoking habits prevalent among members of the lower social-economic classes, the risks of the Western lifestyle as such apply to the overall general population. In view of the traditional attention given to lifestyle risks in the prevention of cardiovascular diseases, the question arises what the new genetic-diagnostic techniques imply for our perspective on such diseases. Does the introduction of genetic techniques indeed result in a shift of attention from the risks of a particular lifestyle to the risks of specific genetic aberrations? If so, how does it work and how does it affect the control and responsibility that we attribute to individuals when it comes to their health?
To answer these questions I take a close look at one specific example, namely the introduction of a genetic approach to hypercholesterolaemia as developed in the Netherlands over the past 15 years. In this chapter, I analyse how this new approach relates to the already existing views and practices involving cholesterol. It will become clear that it takes a lot of effort to define a genetic risk group, but that the demarcation of this risk group is not accepted without resistance. In fact, the genetic high-risk approach clashes with existing approaches in which the general population's risks are centre-stage. As such, this struggle is not just about defining risk groups, but also about assigning responsibility for health or disease and legitimizing the spending of public funds. Because this struggle is far from over, this analysis merely provides a limited perspective on the issues involved. It becomes clear, however, what sort of controversies are in
